Physician profile
Mark M Levy
NPI 1821193921
$16,609.20
in general payments reported to CMS, 2019-2025
9 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,960 · 2020: $13K · 2021: $211 · 2022: $815 · 2023: $373 · 2024: $307 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $12,500.00 | 2020 | |
| Silk Road Medical, INC. | $1,462.99 | 2019 | |
| Medtronic, INC. | $1,217.42 | 2021-2024 | Endurant Iis, Harmony |
| Medtronic Vascular, INC. | $691.82 | 2019-2020 | |
| Penumbra, INC. | $271.22 | 2022-2024 | Penumbra System |
| Shockwave Medical, INC | $178.15 | 2022 | |
| Abbott Laboratories | $150.00 | 2025 | Xact |
| Bolton Medical INC | $98.50 | 2019 | |
| Cook Medical LLC | $39.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.